Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Michelle E. Bouvier
Fludarabine and 2-Gy TBI Is Superior to 2 Gy TBI as Conditioning for HLA-Matched Related Hematopoietic Cell Transplantation: A Phase III Randomized Trial
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Non-Myeloablative Allogeneic Haematopoietic Cell Transplantation for Relapsed Diffuse Large B-Cell Lymphoma: A Multicentre Experience
British Journal of Haematology
Hematology
Related publications
Transplant Conditioning With Treosulfan/Fludarabine With or Without TBI. A Randomized Phase II Trial in Patients With MDS and AML
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Melphalan 140mg/M2 Combined With TBI2(4)Gy and Fludarabine 125mg/M2 as Conditioning for Elderly Patients With Hematological Malignancies in Unrelated Bone Marrow Transplantation Is Comparable in Safety and Effectiveness With TBI/Cy for Younger Patients
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Thiotepa/Cyclophosphamide/Tbi as a Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Myelodysplastic Syndrome
Bone Marrow Transplantation
Transplantation
Hematology
Thiotepa and Fractionated TBI Conditioning Prior to Allogeneic Stem Cell Transplantation for Advanced Hematologic Malignancies: A Phase II Single Institution Trial
Bone Marrow Transplantation
Transplantation
Hematology
Treatment of Fanconi Anemia Patients Using Fludarabine and Low-Dose TBI, Followed by Unrelated Donor Hematopoietic Cell Transplantation
Bone Marrow Transplantation
Transplantation
Hematology
Reduced-Intensity Conditioning Using Fludarabine With Either Antithymocyte Globulin and BU, or Low-Dose TBI Allowing Allogeneic Hematopoietic SCT
Bone Marrow Transplantation
Transplantation
Hematology
Toxicity and Efficacy of Busulfan and Fludarabine Myeloablative Conditioning for HLA-identical Sibling Allogeneic Hematopoietic Cell Transplantation in AML and MDS
Bone Marrow Transplantation
Transplantation
Hematology
MA05.07 Dose Escalated Chemo-Rt to 84 Gy in Stage III NSCLC Appears Excessively Toxic: Results From a Randomized Phase II Trial
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Comparison of Total Body Irradiation (TBI) Conditioning With Non-Tbi for Autologous Stem Cell Transplantation in Newly Diagnosed or Relapsed Mature T- And NK-Cell Non-Hodgkin Lymphoma
Cancer Research and Treatment
Cancer Research
Oncology
